awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38360962-269C2611-6436-455E-A1A5-28484BFC4AFB
Q38360962-269C2611-6436-455E-A1A5-28484BFC4AFB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38360962-269C2611-6436-455E-A1A5-28484BFC4AFB
Multiple myeloma: Updates for pharmacists in the treatment of relapsed and refractory disease.
P2860
Q38360962-269C2611-6436-455E-A1A5-28484BFC4AFB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38360962-269C2611-6436-455E-A1A5-28484BFC4AFB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
750dbc02a644291f8d7341a442041944eee5a431
P2860
Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study.